Vasorelaxation induced by the new nitric oxide donor cis-[Ru(Cl)(bpy)2(NO)](PF6) is due to activation of KCa by a cGMP-dependent pathway

Vascular Pharmacology

Volumn 47, Issue 2-3, 2007, Pages 139-144

  Lunardi, Claure N ^a   Vercesi, Juliana A ^a   da Silva, Roberto S ^a   Bendhack, Lusiane M ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

K+ channels; Nitric oxide; NO donor; Ruthenium complex; Vasorelaxation

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; AMINOPYRIDINE; APAMIN; CYCLIC GMP; GLIBENCLAMIDE; GUANYLATE CYCLASE INHIBITOR; IBERIOTOXIN; PHENYLEPHRINE; POTASSIUM CHANNEL BLOCKING AGENT; RUTHENIUM COMPLEX;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA FLOW; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; DRUG STRUCTURE; ENZYME INHIBITION; LIGHT IRRADIANCE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; RAT; STRUCTURE ANALYSIS; VASCULAR RING; VASODILATATION;

ANIMALS; AORTA, THORACIC; CYCLIC GMP; DOSE-RESPONSE RELATIONSHIP, DRUG; GUANYLATE CYCLASE; LIGHT; MALE; NITRIC OXIDE; NITRIC OXIDE DONORS; ORGANOMETALLIC COMPOUNDS; PHENYLEPHRINE; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS, CALCIUM-ACTIVATED; POTASSIUM CHLORIDE; RATS; RATS, WISTAR; RUTHENIUM; VASODILATION;

EID: 34447628640     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vph.2007.05.003     Document Type: Article

References (27)

1. Bolotina V.M., Najibi S., Palacino J.J., Pagano P.J., and Cohen R.A. Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature 368 (1994) 850-853
2. Bonaventura D., Oliveira F.D., Togniolo V., Tedesco A.C., da Silva R.S., and Bendhack L.M. A macrocyclic nitrosyl ruthenium complex is a NO donor that induces rat aorta relaxation. Nitric Oxide: Biology and Chemistry 10 (2004) 83-91
3. Brayden J.E. Potassium channels in vascular smooth muscle. Clin. Exp. Pharmacol. Physiol. 23 (1996) 1069-1076
4. Cauvin C., Loutzenhiser R., and van Breemen C. Mechanisms of calcium antagonist-induced vasodilation. Annu. Rev. Pharmacol. Toxicol. 23 (1983) 373-396
5. Feelisch M., Noack E., and Schroder H. Explanation of the discrepancy between the degree of organic nitrate decomposition, nitrite formation and guanylate cyclase stimulation. Eur. Heart J. 9 Suppl A (1988) 57-62
6. Hempelmann R.G., Seebeck J., Ziegler A., and Mehdorn H.M. Effects of potassium channel inhibitors on the relaxation induced by the nitric oxide donor diethylamine nitric oxide in isolated human cerebral arteries. J. Neurosurg. 93 (2000) 1048-1054
7. Hempelmann R.G., Seebeck J., Kruse M.L., Ziegler A., and Mehdorn H.M. Role of potassium channels in the relaxation induced by the nitric oxide (NO) donor DEA/NO in the isolated rat basilar artery. Neurosci. Lett. 313 (2001) 21-24
8. Ignarro L.J. Nitric oxide as a unique signaling molecule in the vascular system: a historical overview. J. Physiol. Pharmacol. 53 (2002) 503-514
9. Kanu A., Whitfield J., and Leffler C.W. Carbon monoxide contributes to hypotension-induced cerebrovascular vasodilation in piglets. Am. J. Physiol, Heart Circ. Physiol. 291 (2006) H2409-H2414
10. Kinoshita H., Iwahashi S., Kakutani T., Mizumoto K., Iranami H., and Hatano Y. The role of endothelium-derived nitric oxide in relaxations to levcromakalim in the rat aorta. Jpn. J. Pharmacol. 81 (1999) 362-366
11. Korovkina V.P., and England S.K. Molecular diversity of vascular potassium channel isoforms. Clin. Exp. Pharmacol. Physiol. 29 (2002) 317-323
12. + channels in photorelaxation of vascular smooth muscle. Eur. J. Pharmacol. 347 (1998) 215-221
13. Lunardi C.N., Cacciari A., Silva R.S., and Bendhack L.M. Cytosolic calcium concentration is reduced by photolysis of a nitrosyl ruthenium complex in vascular smooth muscle cells. Nitric oxide 15 (2006) 252-258
14. 2+ reduction under visible light irradiation. Faseb J. 20 (2006) A660-A661
15. McDonald L.J., and Murad F. Nitric oxide and cyclic GMP signaling. Proc. Soc. Exp. Biol. Med. 211 (1996) 1-6
16. Murad F. Regulation of cytosolic guanylyl cyclase by nitric oxide: the NO-cyclic GMP signal transduction system. Adv. Pharmacol. 26 (1994) 19-33
17. Nelson M.T., and Quayle J.M. Physiological roles and properties of potassium channels in arterial smooth muscle. Am. J. Physiol., Cell Physiol. 268 (1995) C799-C822
18. Noack E., and Feelisch M. Molecular mechanisms of nitrovasodilator bioactivation. Basic Res. Cardiol. 86 Suppl 2 (1991) 37-50
19. Sand A., Andersson E., and Fried G. Nitric oxide donors mediate vasodilation in human placental arteries partly through a direct effect on potassium channels. Placenta 27 (2006) 181-190
20. Sato K., Ninomiya H., Ohkura S., Ozaki H., and Nasu T. Impairment of PAR-2-mediated relaxation system in colonic smooth muscle after intestinal inflammation. Br. J. Pharmacol. 148 (2006) 200-207
21. Sobey C.G. Potassium channel function in vascular disease. Arterioscler. Thromb. Vasc. Biol. 21 (2001) 28-38
22. Tanaka Y., Tang G., Takizawa K., Otsuka K., Eghbali M., Song M., Nishimaru K., Shigenobu K., Koike K., Stefani E., and Toro L. Kv channels contribute to nitric oxide- and atrial natriuretic peptide-induced relaxation of a rat conduit artery. J. Pharmacol. Exp. Ther. 317 (2006) 341-354
23. van Breemen C., Cauvin C., Yamamoto H., and Zschauer A. Vascular smooth muscle calcium channels. J. Cardiovasc. Pharmacol. 10 Suppl 10 (1987) S10-S16
24. van der Zypp A., and Majewski H. Effect of cGMP inhibitors on the actions of nitrodilators in rat aorta. Clin. Exp. Pharmacol. Physiol. 25 (1998) 38-43
25. Vergara C., Latorre R., Marrion N.V., and Adelman J.P. Calcium-activated potassium channels. Curr. Opin. Neurobiol. 8 (1998) 321-329
26. Wang Y.X., Legzdins P., Poon J.S., and Pang C.C.Y. Vasodilator effects of organotransition-metal nitrosyl complexes, novel nitric oxide donors. J. Cardiovasc. Pharmacol. 35 (2000) 73-77
27. Zhou W., Wang X.L., Lamping K.G., and Lee H.C. Inhibition of protein kinase cbeta protects against diabetes-induced impairment in arachidonic acid dilation of small coronary arteries. J. Pharmacol. Exp. Ther. 319 (2006) 199-207